Trials / Completed
CompletedNCT00610064
Brain Effects of Sacral Neuromodulation
Brain Effects of Sacral Neuromodulation in Patients With Refractory Lower Urinary Tract Dysfunction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Sacral neuromodulation (SNM) has become an accepted treatment for patients with refractory lower urinary tract dysfunction such as urgency frequency syndrome, urgency incontinence, non-obstructive chronic urinary retention and chronic pelvic pain syndrome. Modulation of central afferent activity is considered critical to this therapeutic effect but the neural mechanisms are poorly understood. We hypothesize that SNM has a significant effect on brain activity detectable by positron emission tomography (PET).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Baseline neuroimaging | Baseline neuroimaging using PET and MRI of the brain in patients before sacral neuromodulation |
| RADIATION | Neuroimaging during sacral neuromodulation | Neuroimaging during sacral neuromodulation using PET |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2008-02-07
- Last updated
- 2010-02-05
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00610064. Inclusion in this directory is not an endorsement.